Intrastriatal infusion of (±)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: An in vivo microdialysis study in chloral hydrate-anesthetized rats

Journal of Neurochemistry

Volumn 66, Issue 5, 1996, Pages 1971-1980

  West, Anthony R ^a   Galloway, Matthew P ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

( ) S Nitroso N acetylpenicillamine; AMPA kainate receptor; Dopamine; Guanylyl cyclase; Nitric oxide; NMDA receptor; Striatum

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; CHLORAL HYDRATE; DOPAMINE; DRUG DERIVATIVE; GLUTAMATE RECEPTOR; GUANYLATE CYCLASE; MAGNESIUM; N ACETYL S NITROSOPENICILLAMINE; PENICILLAMINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE;

ANESTHESIA; ANIMAL; ARTICLE; CORPUS STRIATUM; DRUG ANTAGONISM; INJECTION; MALE; METABOLISM; MICRODIALYSIS; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; ANIMAL EXPERIMENT; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; NEUROTRANSMISSION; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL;

ANESTHESIA; ANIMALS; CHLORAL HYDRATE; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GUANYLATE CYCLASE; INJECTIONS; MAGNESIUM; MALE; MICRODIALYSIS; PENICILLAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 0029659004     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66051971.x     Document Type: Article

References (65)

1. Alagarsamy S., Lonart G., and Johnson K. M. (1994) Regulation of nitric oxide synthase activity in cortical slices by excitatory amino acids and calcium. J. Neurosci. Res. 38, 648-653.
2. Ariano M. A. (1983) Distribution of the components of the guanosine 3′,5′-phosphate system in rat caudate-putamen. Neuroscience 10, 707-723.
3. Anano M. A. (1984) Rat cyclic nucleotide-reactive cells and acetylcholinesterase reactive interneurons are separate populations. Brain Res. 296, 160-163.
4. Beasley D., Schwartz J. H., and Brenner B. M. (1991) Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vasculature smooth muscle cells. J. Clin. Invest. 87, 602-608.
5. Benloucif S. and Galloway M. P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200, 1-8.
6. Benloucif S. B., Keegan M. J., and Galloway M. P. (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265, 373-377.
7. Black M. D., Matthews E. K., and Humphrey P. P. A. (1994) The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro. Neuropharmacology 33, 1357-1365.
8. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane anesthetized rat. Neuropharmacology 34, 269-279.
9. Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T , and Snyder S. H. (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH-diaphorase. Neuron 7, 615-624.
10. Carter C. J., L'Heureux R., and Scatton B. (1988) Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study. J. Neurochem. 51, 462-468.
11. Chéramy A., Romo R., Godehue G., Baruch P., and Glowinski J. (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitory or inhibitory influence of L-glutamate. Neuroscience 19, 1081-1090.
12. Chéramy A., Desce J. M., Godehue G., and Glowinski J. (1994) Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes. Neurochem. Int. 25, 145-154.
13. Dahlström A. and Fuxe K. (1964) Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons Acta Physiol. Scand. 62 (Suppl. 232), 1-55.
14. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., and Snyder S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
15. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
16. Glowinski J., Chèramy A., Romo R., and Barbeito L. (1988) Presynaptic regulation of dopaminergic transmission in the striatum. Cell. Mol. Neurobiol. 8, 7-17.
17. Gross P. M., Weaver D. F., Bowers R. J., Nag S., Ho L. T., Pang J. J., and Espinosa F. J. (1994) Neurotoxicity in conscious rats following intraventricular SNAP, a nitric oxide donor. Neuropharmacology 33, 915-927.
18. Guevara-Guzman R., Emson P. C., and Kendrick K. M. (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62, 807-810.
19. Hamilton M. E, Mele A., and Pert A. (1992) Striatal extracellular dopamine in conscious vs. anesthetized rats: effects of chloral hydrate anesthetic on responses to drugs of different classes. Brain Res. 597, 1-7.
20. 3H]-dopamine from striatal slices. Neuroreport 3, 409-412.
21. Jones N. M., Loiacono R. E., Moller M., and Beart P. M. (1994) Diverse roles for nitric oxide in synaptic signalling after activation of NMDA release-regulating receptors. Neuropharmacology 33, 1351-1356.
22. Kawada T., Ishibashi T., Sasage H., Kato K., and Imai S. (1994) Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig, and rabbit. Gen. Pharmacacol. 25, 1361-1371.
23. Keefe K. A., Zigmond M. J., and Abercrombie E. D. (1993) In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J. Neural Transm. 91, 223-240.
24. Kharazia V. N., Schmidt H. H. H. W., and Weinberg R. J. (1994) Type 1 nitric oxide synthase fully accounts for NADPH-diaphorase in rat striatum but not cortex. Neuroscience 62, 983-987.
25. Kiss J. P., Toth E., Lajtha A., and Vizi E. S. (1994) NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study. Brain Res. 641, 145-148.
26. Kobari M., Fukuuchi Y., Tomita M., Tanahashi N., and Takeda H. (1994) Role of nitric oxide in regulation of cerebral microvasculature tone and autoregulation of cerebral blood flow in cats. Brain Res. 667, 255-262.
27. Kowall N. W., Beal M. F., Ferrante R. J., and Martin J. B. (1985) Topography of nicotinamide adenine dinucleotide phosphate-diaphorase staining neurons in rat striatum. Neurosci. Lett. 59, 61-66.
28. Krebs M. O., Desce J. M., Kemel M. L., Gauchy C., Godeheu G., Cheramy A., and Glowinski J. (1991) Glutamatergic control of dopaminergic release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85.
29. Lawrence A. J. and Jarrott B. (1993) Nitric oxide increases interstitial excitatory amino acid release in the rat dorsomedial medulla oblongata. Neurosci. Lett. 151, 126-129.
30. Lei S. Z., Pan Z. H., Aggarwal S. K., Chen H. S. V., Hartman J., Sucher N. J., and Lipton S. A. (1992) Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8, 1087-1099.
31. Leslie C. A., Liebermann J., and Bennett J. P. (1994) Nitric oxide dependence of striatal NMDA-stimulated dopamine release: an in vivo microdialysis study. Soc. Neurosci. Abstr. 20, 284.
32. Light D. B., Schwiebert E. M., Karlson K. H., and Stanton B. A. (1989) Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 243, 383-385.
33. Lin A. M.-Y., Kao L.-S., and Chai C. Y. (1995) Involvement of nitric oxide in dopaminergic transmission in rat striatum: an in vivo electrochemical study. J. Neurochem. 65, 2043-2049.
34. Lipton S. A. and Stamler J. S. (1994) Actions of redox-related cogeners of nitric oxide at the NMDA receptor. Neuropharmacology 33, 1229-1233.
35. 3H]glutamate by striatal synaptosomes. J. Neurochem. 63, 2108-2117.
36. 3H] dopamine release from striatal slices. J. Neurosci. Res. 35, 192-198.
37. 2 consumption in rat. Brain Res. 669, 35-40.
38. Manzoni O. and Bockaert J. (1993) Nitric oxide activity endogenously modulates NMDA receptors. J. Neurochem. 61, 368-370.
39. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., and Fagni L. (1992) Nitric oxide-induced blockade of NMDA receptors. Neuron 8, 653-662.
40. Moghaddam B. and Bolinao M. L. (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse 18, 337-342.
41. Moghaddam B., Gruen R. J., Roth R. H., Bunney B. S., and Adams R. N. (1990) Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res. 518, 55-60.
42. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B., and Friedlander M. J. (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263, 973-977.
43. Morari M., O'Connor W. T., Ungerstedt U., and Fuxe K. (1993) N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study. J. Neurochem. 60, 1884-1893.
44. Nakahara K., Yokoo H , Yoshida M., Tanaka M., and Shigemori M. (1994) Effect of nitric oxide on central dopamine neurons. Brain Nerve 46, 1147-1153.
45. Ohta K., Araki N., Shibata J., Komatsumoto S., Shimazu K., and Fukuuchi Y. (1994) Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes. Neurosci. Res. 21, 83-89.
46. Overton P. and Clark D. (1991) N-Methyl-D-aspartate increases the excitability of nigrostriatal dopamine terminals. Eur. J. Pharmacol. 201, 117-120.
47. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
48. 3H]-glutamate transport in synaptosomes. Synapse 18, 21-26.
49. 3H]-dopamine uptake. Brain Res. 641, 83-91.
50. Robinson T. E. and Whishaw I. Q. (1988) Normalization of extracellular dopamine in striatum following recovery of a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res. 450, 209-224.
51. Schmidt M. J., Sawyer B. D., Truex L. L., Marshall W. S., and Fleisch J. H. (1985) LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 232, 764-769.
52. Silva M. T., Rose S., Hindmarsh J. G., Aislaitner G., Gorrod J. W., Moore P. K., Jenner P., and Marsden C. D. (1995) Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole. Br. J. Pharmacol. 114, 257-258.
53. Southern E. and Garthwaite J. (1991) Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci. Lett. 130, 107-111.
54. 3H]norepinephrine from rat hippocampal slices. Neuropharmacology 33, 1367-1374.
55. Strasser A., McCarron R. M., Ishii H., Stanimirovic D., and Spatz M. (1994) L-Arginine induces dopamine release from the striatum in vivo. Neuroreport 5, 2298-2300.
56. w-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266, 6259-6263.
57. Toth E., Sershen H., Hashim A., Vizi E. S., and Lajtha A. (1992) Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem. Res. 17, 265-271.
58. Vincent S. R. and Johansson O. (1983) Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscope study. J. Comp. Neurol. 217, 264-270.
59. West A. R. and Galloway M. P. (1996) Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms. Synapse (in press).
60. Wheeler D., Bautelle M. G., and Fillenz M. (1995) The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 65, 767-774.
61. Xu M., Yamamoto T., and Kato T. (1990) In vivo striatal dopamine release by M1 muscarinic receptors is induced by activation of protein kinase C. J. Neurochem. 54, 1917-1919.
62. Yadid G., Pacak I., Kopin I. J., and Goldstein D. S. (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Exp. Pharmacol. Ther. 270, 1158-1165.
63. Zhou M., Kandel E. R., and Hawkins R. D. (1994a) Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus. Neuroreport 5, 1033-1036.
64. Zhou M., Hu Y., Schultz C., Kandel E. R., and Hawkins R. D. (1994b) Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368, 635-639.
65. Zhu X.-Z. and Luo L.-G. (1992) Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59, 932-935.